Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxo4
|
ENSMUSG00000042903.7 | forkhead box O4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_101254013_101254700 | Foxo4 | 172 | 0.889160 | -0.26 | 5.6e-02 | Click! |
chrX_101254732_101255041 | Foxo4 | 65 | 0.939452 | -0.08 | 5.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_138424645_138424892 | 11.30 |
Lmo3 |
LIM domain only 3 |
153 |
0.94 |
chr17_83098800_83099006 | 10.86 |
Gm46606 |
predicted gene, 46606 |
16732 |
0.18 |
chr3_85300229_85300586 | 9.47 |
1700036G14Rik |
RIKEN cDNA 1700036G14 gene |
17112 |
0.24 |
chr15_67417761_67417953 | 7.85 |
1700012I11Rik |
RIKEN cDNA 1700012I11 gene |
191088 |
0.03 |
chr2_26594675_26595827 | 7.85 |
Egfl7 |
EGF-like domain 7 |
3104 |
0.11 |
chr13_70193045_70193196 | 7.74 |
Gm26018 |
predicted gene, 26018 |
24288 |
0.17 |
chr12_26930273_26930439 | 7.74 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
95483 |
0.09 |
chr5_9726061_9726270 | 7.73 |
Grm3 |
glutamate receptor, metabotropic 3 |
995 |
0.6 |
chr5_135544822_135545976 | 7.45 |
Hip1 |
huntingtin interacting protein 1 |
279 |
0.87 |
chr2_181766899_181767258 | 6.98 |
Myt1 |
myelin transcription factor 1 |
36 |
0.97 |
chr18_26847440_26847591 | 6.97 |
Gm49976 |
predicted gene, 49976 |
70582 |
0.12 |
chr3_55756852_55757100 | 6.84 |
Mab21l1 |
mab-21-like 1 |
25534 |
0.18 |
chr12_37774409_37774621 | 6.66 |
Dgkb |
diacylglycerol kinase, beta |
43211 |
0.2 |
chr6_36723290_36723453 | 6.46 |
Gm25111 |
predicted gene, 25111 |
23974 |
0.22 |
chr16_91191775_91191926 | 6.43 |
Gm49613 |
predicted gene, 49613 |
16516 |
0.11 |
chr7_89464437_89464588 | 6.38 |
AI314278 |
expressed sequence AI314278 |
38173 |
0.11 |
chr16_34572536_34572959 | 6.27 |
Kalrn |
kalirin, RhoGEF kinase |
785 |
0.75 |
chr2_105674521_105675719 | 6.24 |
Pax6 |
paired box 6 |
11 |
0.97 |
chr14_118322868_118323035 | 6.13 |
Gm32093 |
predicted gene, 32093 |
26 |
0.97 |
chr17_46454777_46454952 | 6.08 |
Gm5093 |
predicted gene 5093 |
14767 |
0.09 |
chr3_3831527_3831694 | 6.03 |
Gm2071 |
predicted gene 2071 |
2326 |
0.38 |
chr12_35897001_35897152 | 6.00 |
Agr3 |
anterior gradient 3 |
28544 |
0.18 |
chr12_29532917_29533068 | 5.90 |
Myt1l |
myelin transcription factor 1-like |
393 |
0.85 |
chr2_10788471_10788622 | 5.84 |
Gm18547 |
predicted gene, 18547 |
105163 |
0.03 |
chr14_14949137_14949288 | 5.82 |
Nek10 |
NIMA (never in mitosis gene a)- related kinase 10 |
18637 |
0.22 |
chr18_58394837_58395390 | 5.82 |
Slc27a6 |
solute carrier family 27 (fatty acid transporter), member 6 |
161144 |
0.04 |
chr12_13035214_13035436 | 5.82 |
Gm48209 |
predicted gene, 48209 |
19404 |
0.16 |
chr1_51617502_51617987 | 5.66 |
Gm17767 |
predicted gene, 17767 |
21026 |
0.21 |
chr1_172026414_172026906 | 5.66 |
Vangl2 |
VANGL planar cell polarity 2 |
51 |
0.96 |
chr2_58586322_58586614 | 5.60 |
Upp2 |
uridine phosphorylase 2 |
2792 |
0.3 |
chr5_14195253_14195432 | 5.59 |
Sema3e |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
34765 |
0.18 |
chr13_15113489_15113655 | 5.48 |
Gm48338 |
predicted gene, 48338 |
5059 |
0.25 |
chr19_23959939_23960407 | 5.43 |
Fam189a2 |
family with sequence similarity 189, member A2 |
16262 |
0.16 |
chr14_73425854_73426039 | 5.33 |
Itm2b |
integral membrane protein 2B |
40657 |
0.13 |
chr17_31767469_31767801 | 5.28 |
Gm49999 |
predicted gene, 49999 |
21869 |
0.14 |
chr11_35856666_35857239 | 5.23 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
3398 |
0.24 |
chr9_30284815_30284966 | 5.22 |
Gm26435 |
predicted gene, 26435 |
7084 |
0.29 |
chr10_87494268_87494649 | 5.22 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
798 |
0.64 |
chr1_96301388_96301558 | 5.14 |
Gm22917 |
predicted gene, 22917 |
1673 |
0.4 |
chr10_51154132_51154343 | 5.12 |
Gm26257 |
predicted gene, 26257 |
28062 |
0.22 |
chr6_94631563_94631737 | 5.11 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
23875 |
0.17 |
chr5_113491035_113491220 | 5.08 |
Wscd2 |
WSC domain containing 2 |
375 |
0.89 |
chr19_47493646_47493894 | 5.05 |
Stn1 |
STN1, CST complex subunit |
15003 |
0.15 |
chr13_110280472_110281172 | 5.03 |
Rab3c |
RAB3C, member RAS oncogene family |
79 |
0.98 |
chr14_54913433_54913619 | 5.02 |
Slc22a17 |
solute carrier family 22 (organic cation transporter), member 17 |
394 |
0.62 |
chr4_39344820_39345025 | 5.01 |
Gm23607 |
predicted gene, 23607 |
49459 |
0.14 |
chr12_29368602_29368857 | 5.00 |
Gm6989 |
predicted gene 6989 |
51161 |
0.17 |
chr1_56834636_56834821 | 5.00 |
Satb2 |
special AT-rich sequence binding protein 2 |
135112 |
0.05 |
chr3_37204026_37204455 | 5.00 |
Gm12532 |
predicted gene 12532 |
21355 |
0.1 |
chr16_24782003_24782154 | 4.98 |
Mir28a |
microRNA 28a |
45777 |
0.16 |
chrX_150441102_150441358 | 4.94 |
Tmem29 |
transmembrane protein 29 |
67 |
0.97 |
chr8_47218677_47218836 | 4.87 |
Stox2 |
storkhead box 2 |
1437 |
0.44 |
chr13_34129793_34130880 | 4.84 |
Tubb2b |
tubulin, beta 2B class IIB |
18 |
0.96 |
chr6_127701185_127701975 | 4.83 |
Gm43634 |
predicted gene 43634 |
57140 |
0.08 |
chr17_56406722_56406880 | 4.80 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
7629 |
0.14 |
chr6_63256767_63257230 | 4.80 |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
172 |
0.85 |
chr6_70824227_70825026 | 4.79 |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
19889 |
0.13 |
chr4_19569392_19570378 | 4.77 |
Cpne3 |
copine III |
198 |
0.94 |
chr19_40434410_40434919 | 4.76 |
Sorbs1 |
sorbin and SH3 domain containing 1 |
16723 |
0.21 |
chr9_58111541_58111738 | 4.75 |
Ccdc33 |
coiled-coil domain containing 33 |
2721 |
0.19 |
chr1_150949983_150950458 | 4.74 |
Hmcn1 |
hemicentin 1 |
42831 |
0.14 |
chr12_38501010_38501161 | 4.74 |
4930428E07Rik |
RIKEN cDNA 4930428E07 gene |
113436 |
0.06 |
chr5_75835180_75835470 | 4.72 |
Gm19590 |
predicted gene, 19590 |
320 |
0.87 |
chr3_13866409_13866595 | 4.72 |
Gm19114 |
predicted gene, 19114 |
26271 |
0.23 |
chr13_84344282_84344641 | 4.71 |
Gm26927 |
predicted gene, 26927 |
4348 |
0.26 |
chr2_157464727_157465479 | 4.71 |
Src |
Rous sarcoma oncogene |
8018 |
0.18 |
chr15_31297511_31297662 | 4.71 |
Ankrd33b |
ankyrin repeat domain 33B |
10608 |
0.14 |
chr14_7819589_7819757 | 4.67 |
Flnb |
filamin, beta |
1716 |
0.31 |
chr4_120262139_120262290 | 4.62 |
Foxo6 |
forkhead box O6 |
25135 |
0.18 |
chr18_38145397_38145604 | 4.57 |
Pcdh1 |
protocadherin 1 |
57663 |
0.08 |
chr5_26991582_26992107 | 4.51 |
Gm16057 |
predicted gene 16057 |
15777 |
0.25 |
chr1_41743415_41743572 | 4.49 |
Gm29260 |
predicted gene 29260 |
38315 |
0.23 |
chr12_116485218_116485891 | 4.47 |
Ptprn2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
166 |
0.93 |
chr1_135583884_135584220 | 4.46 |
Gm4793 |
predicted gene 4793 |
721 |
0.55 |
chr3_137647545_137647703 | 4.46 |
Gm30946 |
predicted gene, 30946 |
2843 |
0.19 |
chr15_96547848_96548240 | 4.46 |
Slc38a1 |
solute carrier family 38, member 1 |
31540 |
0.17 |
chr1_84710201_84710701 | 4.46 |
Dner |
delta/notch-like EGF repeat containing |
14230 |
0.15 |
chr14_66320257_66320561 | 4.45 |
Gm41183 |
predicted gene, 41183 |
20820 |
0.13 |
chr5_74677462_74677688 | 4.44 |
Lnx1 |
ligand of numb-protein X 1 |
54 |
0.97 |
chr19_42431698_42432696 | 4.39 |
Crtac1 |
cartilage acidic protein 1 |
412 |
0.84 |
chr14_122449967_122450118 | 4.38 |
Gm5089 |
predicted gene 5089 |
1073 |
0.4 |
chr18_60923916_60924296 | 4.37 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
1512 |
0.31 |
chr10_60752094_60753281 | 4.35 |
Slc29a3 |
solute carrier family 29 (nucleoside transporters), member 3 |
95 |
0.97 |
chr10_10812841_10813013 | 4.32 |
4930567K20Rik |
RIKEN cDNA 4930567K20 gene |
61847 |
0.11 |
chr7_16033159_16033362 | 4.22 |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
14661 |
0.12 |
chr17_80969670_80969950 | 4.18 |
Tmem178 |
transmembrane protein 178 |
25178 |
0.19 |
chr1_16228282_16228916 | 4.13 |
Gm28095 |
predicted gene 28095 |
93 |
0.97 |
chr16_44538220_44538681 | 4.12 |
Mir3081 |
microRNA 3081 |
19679 |
0.18 |
chr6_124493335_124494220 | 4.09 |
Gm44096 |
predicted gene, 44096 |
591 |
0.4 |
chr9_99632474_99632625 | 4.08 |
Dzip1l |
DAZ interacting protein 1-like |
2312 |
0.26 |
chr2_181767288_181767480 | 4.07 |
Myt1 |
myelin transcription factor 1 |
62 |
0.96 |
chr5_129724468_129725740 | 4.06 |
Nipsnap2 |
nipsnap homolog 2 |
3 |
0.95 |
chr17_56142066_56142377 | 4.02 |
Sema6b |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B |
1878 |
0.17 |
chr17_60267150_60267583 | 4.02 |
Gm29051 |
predicted gene 29051 |
136491 |
0.05 |
chr4_110050502_110051534 | 4.01 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chr16_57302914_57303208 | 4.01 |
Tmem30c |
transmembrane protein 30C |
10196 |
0.14 |
chr8_78550170_78550321 | 4.00 |
Slc10a7 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 7 |
27506 |
0.16 |
chr2_64394647_64394943 | 4.00 |
Gm13575 |
predicted gene 13575 |
935 |
0.71 |
chr9_40345578_40345834 | 4.00 |
Gramd1b |
GRAM domain containing 1B |
584 |
0.6 |
chr11_25357181_25357562 | 3.99 |
4933427E13Rik |
RIKEN cDNA 4933427E13 gene |
27414 |
0.22 |
chr4_57638055_57638394 | 3.97 |
Pakap |
paralemmin A kinase anchor protein |
249 |
0.95 |
chr17_25609260_25609765 | 3.95 |
Lmf1 |
lipase maturation factor 1 |
30192 |
0.07 |
chr1_130878202_130878527 | 3.95 |
Fcmr |
Fc fragment of IgM receptor |
33 |
0.96 |
chr8_82104806_82104957 | 3.92 |
Gm25267 |
predicted gene, 25267 |
47901 |
0.15 |
chr9_107735007_107735158 | 3.92 |
Rbm5 |
RNA binding motif protein 5 |
9152 |
0.1 |
chr3_50881765_50882103 | 3.91 |
Gm37548 |
predicted gene, 37548 |
5125 |
0.23 |
chr7_44593726_44594565 | 3.89 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
150 |
0.87 |
chr8_122745888_122746261 | 3.87 |
C230057M02Rik |
RIKEN cDNA C230057M02 gene |
6251 |
0.11 |
chr4_22494880_22495651 | 3.84 |
Gm30731 |
predicted gene, 30731 |
4717 |
0.18 |
chr2_109696829_109696980 | 3.84 |
Bdnf |
brain derived neurotrophic factor |
2435 |
0.29 |
chr17_8647698_8647849 | 3.82 |
Gm15425 |
predicted gene 15425 |
78913 |
0.09 |
chr11_24129398_24130415 | 3.80 |
Bcl11a |
B cell CLL/lymphoma 11A (zinc finger protein) |
12473 |
0.15 |
chr16_39453494_39453645 | 3.80 |
Gm24795 |
predicted gene, 24795 |
1446 |
0.49 |
chrX_135796271_135796923 | 3.78 |
Gprasp1 |
G protein-coupled receptor associated sorting protein 1 |
991 |
0.31 |
chr4_155320423_155320574 | 3.76 |
Prkcz |
protein kinase C, zeta |
19327 |
0.14 |
chr9_100271982_100272787 | 3.76 |
Gm28167 |
predicted gene 28167 |
51140 |
0.14 |
chr19_41656109_41656268 | 3.75 |
Slit1 |
slit guidance ligand 1 |
47658 |
0.13 |
chr9_77339668_77339819 | 3.74 |
Mlip |
muscular LMNA-interacting protein |
884 |
0.56 |
chr6_32373945_32374204 | 3.72 |
Plxna4os3 |
plexin A4, opposite strand 3 |
70161 |
0.11 |
chr4_97581822_97582075 | 3.72 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
2648 |
0.32 |
chr3_34322517_34323142 | 3.72 |
Gm38505 |
predicted gene, 38505 |
28883 |
0.19 |
chr3_102010108_102010434 | 3.66 |
Nhlh2 |
nescient helix loop helix 2 |
116 |
0.97 |
chr12_116648943_116649145 | 3.65 |
Gm17807 |
predicted gene, 17807 |
51791 |
0.15 |
chr19_28088001_28088445 | 3.64 |
Gm28228 |
predicted gene 28228 |
633 |
0.76 |
chr7_139806392_139806571 | 3.62 |
Mir6401 |
microRNA 6401 |
27463 |
0.12 |
chr10_108701445_108701650 | 3.61 |
Gm5136 |
predicted gene 5136 |
1387 |
0.53 |
chr2_44632627_44632778 | 3.60 |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
60988 |
0.15 |
chr8_124794723_124794899 | 3.56 |
Trim67 |
tripartite motif-containing 67 |
1719 |
0.25 |
chr3_68096841_68096992 | 3.56 |
Schip1 |
schwannomin interacting protein 1 |
32114 |
0.23 |
chr7_81651384_81651564 | 3.56 |
Gm26149 |
predicted gene, 26149 |
18254 |
0.12 |
chr15_27937965_27938141 | 3.55 |
Trio |
triple functional domain (PTPRF interacting) |
18782 |
0.21 |
chr17_49952081_49952304 | 3.55 |
AC133946.1 |
oxidoreductase NAD-binding domain containing 1 (OXNAD1) pseudogene |
20635 |
0.17 |
chr18_29632452_29632747 | 3.54 |
Gm7917 |
predicted gene 7917 |
24997 |
0.26 |
chr18_69607644_69607795 | 3.53 |
Tcf4 |
transcription factor 4 |
4725 |
0.31 |
chr17_8341461_8341668 | 3.53 |
Prr18 |
proline rich 18 |
825 |
0.47 |
chr15_66239660_66240017 | 3.51 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
46213 |
0.14 |
chr16_44530838_44531222 | 3.50 |
Mir3081 |
microRNA 3081 |
27099 |
0.17 |
chr16_67617697_67618069 | 3.48 |
Cadm2 |
cell adhesion molecule 2 |
2610 |
0.35 |
chr2_181581056_181582098 | 3.46 |
Uckl1 |
uridine-cytidine kinase 1-like 1 |
49 |
0.9 |
chr10_66558156_66558362 | 3.45 |
Gm22594 |
predicted gene, 22594 |
74706 |
0.1 |
chr5_101932977_101933128 | 3.43 |
Wdfy3 |
WD repeat and FYVE domain containing 3 |
2199 |
0.33 |
chrX_12839856_12840190 | 3.42 |
Gm25063 |
predicted gene, 25063 |
30339 |
0.16 |
chr3_9501068_9501275 | 3.40 |
Gm38001 |
predicted gene, 38001 |
5003 |
0.27 |
chr7_118902962_118903291 | 3.40 |
Iqck |
IQ motif containing K |
33997 |
0.13 |
chr4_22667793_22668238 | 3.39 |
Gm11879 |
predicted gene 11879 |
36042 |
0.19 |
chr8_77518027_77518631 | 3.39 |
0610038B21Rik |
RIKEN cDNA 0610038B21 gene |
214 |
0.67 |
chr13_83733998_83734206 | 3.39 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1536 |
0.27 |
chr2_32877861_32878386 | 3.38 |
Fam129b |
family with sequence similarity 129, member B |
2009 |
0.18 |
chr13_28721522_28721681 | 3.36 |
Mir6368 |
microRNA 6368 |
10728 |
0.27 |
chr15_71810215_71810641 | 3.35 |
Gm16308 |
predicted gene 16308 |
320 |
0.87 |
chr8_12430018_12430574 | 3.35 |
Gm25239 |
predicted gene, 25239 |
33893 |
0.1 |
chr11_78113833_78114090 | 3.34 |
Fam222b |
family with sequence similarity 222, member B |
1645 |
0.18 |
chr8_5918032_5918488 | 3.33 |
Gm2734 |
predicted gene 2734 |
76463 |
0.11 |
chr18_26510974_26511155 | 3.32 |
Gm23674 |
predicted gene, 23674 |
15629 |
0.31 |
chr8_16837553_16837768 | 3.32 |
Gm25278 |
predicted gene, 25278 |
14508 |
0.27 |
chr3_89861166_89861391 | 3.30 |
She |
src homology 2 domain-containing transforming protein E |
23389 |
0.1 |
chr17_83099051_83099202 | 3.29 |
Gm46606 |
predicted gene, 46606 |
16509 |
0.18 |
chr2_96318005_96318352 | 3.29 |
Lrrc4c |
leucine rich repeat containing 4C |
9 |
0.99 |
chr13_67194563_67195091 | 3.29 |
Zfp455 |
zinc finger protein 455 |
292 |
0.79 |
chr2_90885432_90885608 | 3.28 |
C1qtnf4 |
C1q and tumor necrosis factor related protein 4 |
340 |
0.78 |
chr1_6733683_6734408 | 3.27 |
St18 |
suppression of tumorigenicity 18 |
825 |
0.73 |
chrX_153831928_153832301 | 3.26 |
Spin2c |
spindlin family, member 2C |
111 |
0.97 |
chr14_34903984_34904163 | 3.26 |
Mir346 |
microRNA 346 |
9464 |
0.25 |
chr4_8421311_8421779 | 3.24 |
Gm37386 |
predicted gene, 37386 |
32702 |
0.18 |
chr17_56468616_56468899 | 3.23 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
5870 |
0.16 |
chr12_71049710_71049861 | 3.22 |
Arid4a |
AT rich interactive domain 4A (RBP1-like) |
1444 |
0.38 |
chr6_39242951_39243777 | 3.20 |
Gm43479 |
predicted gene 43479 |
3250 |
0.2 |
chr15_103115450_103115777 | 3.19 |
Gm28265 |
predicted gene 28265 |
11011 |
0.09 |
chr4_45690210_45690500 | 3.19 |
Gm829 |
predicted gene 829 |
6766 |
0.17 |
chr13_78427126_78427725 | 3.19 |
Gm31946 |
predicted gene, 31946 |
177 |
0.95 |
chr19_9898848_9899750 | 3.18 |
Incenp |
inner centromere protein |
82 |
0.76 |
chr13_34136680_34136848 | 3.17 |
Gm36500 |
predicted gene, 36500 |
2904 |
0.15 |
chr19_26549286_26549437 | 3.17 |
Gm50379 |
predicted gene, 50379 |
18609 |
0.17 |
chr18_55379560_55379763 | 3.17 |
Gm37828 |
predicted gene, 37828 |
40149 |
0.2 |
chr3_134306264_134306415 | 3.16 |
Gm43559 |
predicted gene 43559 |
33829 |
0.13 |
chr10_112203584_112203748 | 3.16 |
Gm47419 |
predicted gene, 47419 |
27475 |
0.13 |
chr15_83771740_83771941 | 3.16 |
Mpped1 |
metallophosphoesterase domain containing 1 |
7627 |
0.23 |
chr12_12738753_12738931 | 3.15 |
3732407C23Rik |
RIKEN cDNA 3732407C23 gene |
15981 |
0.17 |
chr1_57211104_57211255 | 3.15 |
BC055402 |
cDNA sequence BC055402 |
3814 |
0.28 |
chr10_14017823_14018282 | 3.13 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
51028 |
0.13 |
chr12_51900435_51900586 | 3.13 |
Heatr5a |
HEAT repeat containing 5A |
11520 |
0.21 |
chr2_157800841_157801028 | 3.11 |
Ctnnbl1 |
catenin, beta like 1 |
11070 |
0.21 |
chr11_32113166_32113503 | 3.11 |
Gm12108 |
predicted gene 12108 |
12106 |
0.19 |
chr5_49639734_49639933 | 3.10 |
Gm5555 |
predicted pseudogene 5555 |
87675 |
0.08 |
chr9_124439906_124440949 | 3.09 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr7_34570196_34571084 | 3.09 |
Gm12784 |
predicted gene 12784 |
23434 |
0.15 |
chr3_36521809_36521960 | 3.08 |
Gm11549 |
predicted gene 11549 |
71 |
0.95 |
chr14_52009451_52009674 | 3.08 |
Zfp219 |
zinc finger protein 219 |
1013 |
0.3 |
chr9_121062357_121062508 | 3.07 |
Ulk4 |
unc-51-like kinase 4 |
17500 |
0.2 |
chr19_41745643_41746338 | 3.06 |
Slit1 |
slit guidance ligand 1 |
2325 |
0.31 |
chr7_117700147_117700298 | 3.06 |
Gm24063 |
predicted gene, 24063 |
76572 |
0.12 |
chr10_79874050_79875052 | 3.06 |
Plppr3 |
phospholipid phosphatase related 3 |
19 |
0.53 |
chr13_101914745_101915140 | 3.05 |
Gm17832 |
predicted gene, 17832 |
5478 |
0.27 |
chr6_37642704_37643180 | 3.04 |
Ybx1-ps2 |
Y box protein 1, pseudogene 2 |
44253 |
0.17 |
chr4_63402089_63402290 | 3.03 |
Akna |
AT-hook transcription factor |
1165 |
0.38 |
chr12_68997364_68997515 | 3.02 |
Gm47515 |
predicted gene, 47515 |
2469 |
0.27 |
chr12_14859916_14860086 | 3.00 |
Gm26449 |
predicted gene, 26449 |
18494 |
0.24 |
chr11_55791470_55791820 | 2.99 |
Gm12239 |
predicted gene 12239 |
19557 |
0.26 |
chr13_37312653_37312834 | 2.97 |
Gm47711 |
predicted gene, 47711 |
13723 |
0.16 |
chr15_85708879_85709635 | 2.97 |
Mirlet7b |
microRNA let7b |
1938 |
0.23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.7 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.9 | 5.6 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.8 | 5.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.5 | 4.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.5 | 4.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.3 | 11.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.9 | 2.6 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.8 | 2.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.8 | 1.6 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.8 | 2.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.8 | 3.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 2.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.7 | 2.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.7 | 2.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.6 | 4.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.6 | 2.4 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.6 | 1.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.6 | 2.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.6 | 1.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 5.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.5 | 1.6 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.5 | 1.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.5 | 5.1 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.5 | 0.5 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.5 | 2.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.5 | 0.5 | GO:0021550 | medulla oblongata development(GO:0021550) |
0.4 | 2.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 3.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 1.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 1.3 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.4 | 2.6 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.4 | 2.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.4 | 1.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 2.4 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.4 | 2.4 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.4 | 0.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 0.8 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.4 | 1.6 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 2.4 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.4 | 1.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.4 | 2.0 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.4 | 1.9 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.4 | 1.9 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.4 | 1.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.4 | 1.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 0.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.4 | 1.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 2.8 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.4 | 4.9 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 0.7 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 1.4 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.3 | 1.3 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.3 | 1.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 1.3 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 1.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.3 | 1.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 1.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 1.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 1.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 3.9 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.3 | 0.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 0.3 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.3 | 0.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 0.9 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.3 | 0.6 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.3 | 0.9 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.3 | 1.2 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 1.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 0.9 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.3 | 3.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.3 | 0.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.3 | 0.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 1.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 1.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 0.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.3 | 2.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 0.8 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.3 | 0.3 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.3 | 0.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 0.8 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 0.3 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.3 | 1.7 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 0.3 | GO:0072160 | nephron tubule epithelial cell differentiation(GO:0072160) |
0.3 | 2.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.3 | 2.5 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 1.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 1.1 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 1.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 0.8 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 1.9 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 1.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.3 | 0.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.3 | 0.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.3 | 2.9 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 0.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.3 | 1.3 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.3 | 1.0 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.3 | 0.8 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.3 | 0.5 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 0.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 0.8 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 1.8 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.3 | 1.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 0.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.3 | 1.0 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 0.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 0.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.7 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 0.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 0.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.2 | 1.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 1.7 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.5 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.2 | 0.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.2 | 1.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 3.6 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.2 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.2 | 0.4 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.2 | 0.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 0.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.6 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.2 | 1.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.4 | GO:0060686 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.2 | 0.4 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.2 | 0.8 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 4.1 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.2 | 0.6 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.2 | 0.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 1.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 0.4 | GO:0021586 | pons maturation(GO:0021586) |
0.2 | 0.2 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 0.6 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 1.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 1.8 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.8 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 2.2 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.2 | 0.6 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 0.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 1.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 0.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 0.2 | GO:0015846 | polyamine transport(GO:0015846) |
0.2 | 0.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 2.7 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.2 | 3.1 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 1.1 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.2 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 2.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.2 | GO:0070384 | Harderian gland development(GO:0070384) |
0.2 | 0.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 1.5 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 1.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 0.7 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.5 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 1.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 1.5 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 1.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 1.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.2 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.2 | 0.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.5 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.2 | 0.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 0.3 | GO:0048880 | sensory system development(GO:0048880) |
0.2 | 0.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 0.6 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.2 | 2.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 1.1 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 4.5 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 0.8 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 0.5 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.2 | 0.2 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.2 | 0.5 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 0.9 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 1.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 0.3 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 1.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.3 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.6 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.3 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 2.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 0.1 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.1 | 0.7 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.1 | 0.3 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.1 | 0.4 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.7 | GO:0021756 | striatum development(GO:0021756) |
0.1 | 0.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.7 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.8 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 1.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 1.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 1.2 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
0.1 | 0.3 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.5 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 3.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.4 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.9 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 2.2 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.4 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.1 | 0.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.1 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.1 | 0.5 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.1 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.4 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 11.5 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 0.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 5.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 1.2 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.1 | 1.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.5 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.6 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 1.0 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 1.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.7 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.3 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.1 | 0.2 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 0.1 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.1 | 0.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.7 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.3 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 0.4 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.4 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 1.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) regulation of Cdc42 protein signal transduction(GO:0032489) |
0.1 | 0.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.2 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 1.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.6 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.5 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.1 | 0.6 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.7 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.1 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 0.1 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.1 | 0.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 0.4 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 1.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.2 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 5.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.2 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 1.4 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.3 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.5 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.2 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.6 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.2 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 1.4 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.2 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.2 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.1 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.1 | 1.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.2 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.1 | 2.2 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.1 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 1.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.2 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 1.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 1.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.7 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.6 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.3 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.2 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.4 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 1.9 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.1 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.1 | 0.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.1 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 1.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.1 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.1 | 0.2 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.3 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.2 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.1 | 0.5 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.2 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.4 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.1 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.1 | 0.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.1 | 1.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 1.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.2 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.1 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.0 | 0.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.4 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.3 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.9 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.0 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.2 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.6 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.4 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.0 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.2 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.0 | 0.0 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.0 | 1.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 1.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.0 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
0.0 | 3.7 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.2 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.2 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.0 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
0.0 | 0.0 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.0 | 0.1 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.0 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.0 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.1 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.1 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 0.1 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.0 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 1.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.3 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.0 | 0.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.0 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.0 | 0.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.0 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.1 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.7 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.0 | 0.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.2 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.0 | GO:0072298 | regulation of metanephric glomerulus development(GO:0072298) |
0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.2 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.0 | 0.1 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.0 | 0.1 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 0.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 1.3 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.5 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.1 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.0 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.0 | 0.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.5 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.0 | 0.0 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.0 | 0.1 | GO:0032305 | positive regulation of icosanoid secretion(GO:0032305) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.0 | 0.0 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.0 | 0.0 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.0 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.1 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.0 | 0.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.0 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.0 | 0.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.1 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.2 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.0 | 0.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.0 | 0.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.0 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.0 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.0 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.0 | 0.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.4 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.1 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.1 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.0 | GO:0021544 | subpallium development(GO:0021544) |
0.0 | 0.0 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.1 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.5 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.0 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.1 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.0 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.0 | 0.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.0 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.0 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.2 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.0 | GO:0003306 | Wnt signaling pathway involved in heart development(GO:0003306) |
0.0 | 0.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.0 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.0 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.0 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.0 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.0 | 0.0 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.1 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.0 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.0 | 0.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.0 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0010751 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.0 | 0.0 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.0 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.0 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.1 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.0 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.6 | 1.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 0.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.5 | 2.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.5 | 4.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 1.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.4 | 4.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.4 | 1.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 2.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 0.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.4 | 3.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 2.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 1.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 5.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 2.2 | GO:0000801 | central element(GO:0000801) |
0.3 | 0.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 4.7 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 0.6 | GO:0044393 | microspike(GO:0044393) |
0.3 | 0.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 1.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.3 | 2.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 0.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.3 | 0.8 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 0.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 0.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 4.1 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 0.8 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 6.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 0.5 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 1.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 1.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 2.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 0.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 2.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 1.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.7 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 6.1 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.3 | GO:0097433 | dense body(GO:0097433) |
0.1 | 1.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 2.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 11.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 1.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 3.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 4.0 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 3.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.9 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 2.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.0 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.1 | 1.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.8 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.6 | GO:0070187 | telosome(GO:0070187) |
0.1 | 13.1 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.5 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 1.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 1.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 2.8 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.4 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 1.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.5 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 1.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 1.0 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 6.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 2.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 6.2 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.5 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.4 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 1.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.3 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 1.1 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 1.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 1.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.2 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.4 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.1 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 0.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 2.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 1.7 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
0.0 | 0.3 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 2.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.0 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.0 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.0 | GO:0098803 | respiratory chain complex(GO:0098803) |
0.0 | 0.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.0 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.2 | 6.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.9 | 6.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.7 | 3.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 4.7 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.7 | 2.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.7 | 2.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.6 | 2.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.6 | 1.7 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.6 | 1.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 1.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 1.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.5 | 2.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.5 | 2.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 1.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.4 | 2.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 2.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.4 | 3.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 1.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 1.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 5.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.4 | 2.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 1.9 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.4 | 0.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 1.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.4 | 1.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 1.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.3 | 4.8 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.3 | 5.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 2.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 1.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 2.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 0.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 2.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 0.6 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 1.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 5.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 2.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 1.1 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 1.8 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 2.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 2.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 1.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 1.7 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.7 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 0.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 0.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.2 | 1.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 1.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 0.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 2.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 4.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 2.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 2.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 1.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 1.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 2.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 5.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 1.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.7 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 3.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.4 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 4.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 2.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 1.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.6 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.4 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 2.9 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 4.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 2.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 6.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 3.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 1.3 | GO:0070694 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 8.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 3.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.1 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.1 | 1.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.8 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 1.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 0.4 | GO:0034823 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.5 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 4.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.7 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 2.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 1.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.2 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 4.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 4.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 1.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 1.5 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 2.1 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.2 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 1.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.0 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 2.4 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.4 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.0 | 0.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 1.3 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 1.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.0 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.3 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 1.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.6 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 1.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 0.0 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 1.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.0 | 0.0 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 5.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 4.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 4.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 3.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 4.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 2.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 3.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 2.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 7.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.5 | 6.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 0.9 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.4 | 6.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 5.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 4.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 1.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 2.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 4.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 4.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 1.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 1.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 2.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 1.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 2.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 2.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 2.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 4.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 2.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 3.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 4.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 3.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.1 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.5 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 0.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 1.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 1.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.4 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.0 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |